A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers

NCT05206370 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

792

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Cytisinicline
DRUG: Placebo
BEHAVIORAL: Behavioral support

Sponsor

Achieve Life Sciences